Related Experiment Video

Updated: Jul 5, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance

John J Kelly1

  • 1Department of Neurology, The George Washington University Medical Center, Washington, DC, USA.

Reviews in Neurological Diseases
|April 18, 2008
PubMed

Insights

Monoclonal gammopathies (MGs) can impact peripheral nerves. Monoclonal gammopathy of undetermined significance (MGUS) is the most common plasma cell disorder linked to neurologic issues, often classified as IgM or non-IgM types.

Area of Science:

  • Hematology
  • Neurology
  • Oncology

Background:

  • Monoclonal gammopathies (MGs), also known as plasma cell dyscrasias (PCDs), are conditions involving abnormal plasma cell proliferation.
  • These disorders can manifest as peripheral neuropathies, affecting nerve function.
  • A key characteristic is the secretion of a monoclonal protein (M-protein) in serum or urine.

Purpose of the Study:

  • To elucidate the relationship between monoclonal gammopathies and peripheral nerve involvement.
  • To highlight the significance of monoclonal gammopathy of undetermined significance (MGUS) in neurologic disorders.
  • To establish a clinical classification framework for MGUS-associated neuropathies.

Main Methods:

  • Review of existing literature on MGs and their neurologic complications.
  • Clinical classification of MGUS-associated neuropathies based on M-protein type (IgM vs. non-IgM).
  • Analysis of M-protein levels to identify potential malignant transformation.

Main Results:

  • Monoclonal gammopathies are a significant cause of peripheral nerve disorders.
  • MGUS is the most prevalent PCD associated with neurologic conditions.
  • Approximately 50% of MGUS neuropathies involve IgM gammopathy, with the remainder associated with IgG and IgA gammopathies.

Conclusions:

  • MGUS-associated neuropathies can be clinically categorized into IgM and non-IgM types.
  • Monitoring M-protein levels is crucial for detecting malignant transformation from MGUS to PCD.
  • Understanding these classifications aids in the clinical management of patients with MGs and neurologic symptoms.

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...